2018 IQVIA BIOTECH SUMMIT

“Realising the Promise: Addressing the Biotech Life Cycle Challenges”

Join IQVIA’s first UK and Nordics EBP Summit held on 26 June 2018, at the Church House Westminster, London, United Kingdom. Starting with registrations and coffee from 09:30 (see the full agenda here), this first IQVIA UK and Western Europe Biotech Summit will give Emerging Biopharma leaders an opportunity to:

• Hear expert insight on topics such as market valuation, financing, navigating regulatory hurdles through to successful commercialisation
• Network with fellow leaders and share best practice in the biotech space

Chaired by Professor Richard Barker, Founding Director, New Medicine Partners, this event will deliver EBP-tailored insights, with speakers including:

• Gil Bar-Nahum, Managing Director, Jefferies
• Sir Alasdair Breckenridge, Chair, Advisory Board of the Centre of Regulatory Excellence of Duke/NUS in Singapore
• Scott Davis, Head of Therapeutic Strategy, EMEA, IQVIA
• Sarah Haywood, Chief Executive Officer, MedCity
• Alex Pasteur, Partner, F-Prime Capital
• Simone Seiter, Vice President Brand & Commercial Strategy and Global Lead Launch Excellence, IQVIA
• Jayne Spink, Chief Executive, Genetic Alliance UK, Chair of Rare Diseases UK
• Georg Toufar, CEO, Kronberg Associates (Grow. Build. Turn Around)
• Sheela Upadhyaya, Associate Director Highly Specialised Technologies, Centre for Health Technology Evaluation, NICE

Secure your place today as places are limited and are booked on a first come first served basis.